The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia

被引:108
|
作者
Velligan, Dawn I. [1 ]
Diamond, Pamela M. [4 ]
Mintz, Jim [1 ]
Maples, Natalie [1 ]
Li, Xueying [1 ]
Zeber, John [1 ,5 ]
Ereshefsky, Larry [2 ]
Lam, Yui-Wing F. [3 ]
Castillo, Desiree [1 ]
Miller, Alexander L. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78284 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacotherapy Educ & Res, San Antonio, TX 78284 USA
[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78284 USA
[4] Univ Texas Houston, Sch Publ Hlth, Ctr Hlth Promot & Prevent Res, Houston, TX USA
[5] Vet Affairs HSR&D, VERDICT, San Antonio, TX USA
关键词
D O I
10.1093/schbul/sbm111
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Cognitive adaptation training (CAT) is a psychosocial treatment that uses environmental supports such as signs, checklists, alarms, and the organization of belongings to cue and sequence adaptive behaviors in the home. Ninety-five outpatients with schizophrenia (structured clinical interview for diagnosis, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) were randomly assigned to (1) Full-CAT (CAT focused on many aspects of community adaptation including grooming, care of living quarters, leisure skills, social and role performance, and medication adherence), (2) Pharm-CAT (CAT focused only on medication and appointment adherence), or (3) treatment as usual (TAU). Treatment lasted for 9 months, and patients were followed for 6 months after the withdrawal of home visits. Medication adherence (assessed during unannounced, in-home pill counts) and functional outcomes were assessed at 3-month intervals. Results of mixed-effects regression models indicated that both CAT and Pharm-CAT treatments were superior to TAU for improving adherence to prescribed medication (P < .0001). Effects on medication adherence remained significant when home visits were withdrawn. Full-CAT treatment improved functional outcome relative to Pharm-CAT and TAU (P < .0001). However, differences for functional outcome across groups decreased following the withdrawal of home visits and were no longer statistically significant at the 6-month follow-up. Survival time to relapse or significant exacerbation was significantly longer in both CAT and Pharm-CAT in comparison to TAU (.004). Findings indicate that supports targeting medication adherence can improve and maintain this behavior. Comprehensive supports targeting multiple domains of functioning are necessary to improve functional outcomes. Maintenance of gains in functional outcome may require some form of continued intervention.
引用
收藏
页码:483 / 493
页数:11
相关论文
共 50 条
  • [21] Collaborative care to boost medication adherence may not improve outcomes significantly
    Talsma, Julia
    [J]. FORMULARY, 2013, 48 (12) : 380 - 380
  • [22] Impact of splitting risperidone tablets on medication adherence and on clinical outcomes for patients with schizophrenia
    Weissman, Ellen M.
    Dellenbaugh, Cornelia
    [J]. PSYCHIATRIC SERVICES, 2007, 58 (02) : 201 - 206
  • [23] In response to the Commentary to our systematic review 'Does adherence therapy improve medication adherence among patients with schizophrenia?'
    Hegedues, Anna
    Kozel, Bernd
    [J]. INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2015, 24 (04) : 373 - 374
  • [24] Interventions to improve adherence to antipsychotic medication in patients with schizophrenia-A review of the past decade
    Barkhof, E.
    Meijer, C. J.
    de Sonneville, L. M. J.
    Linszen, D. H.
    de Haan, L.
    [J]. EUROPEAN PSYCHIATRY, 2012, 27 (01) : 9 - 18
  • [25] Use of Behavioral Economics to Improve Medication Adherence in Severe Mental Illness
    Guinart, Daniel
    Kane, John M.
    [J]. PSYCHIATRIC SERVICES, 2019, 70 (10) : 955 - 957
  • [26] The use of an electronic medication organizer device with alarm to improve medication adherence of older adults with hypertension
    Vieira, Liliana Batista
    Moreira Reis, Adriano Max
    Ramos, Celso de Avila
    dos Reis, Tiago Marques
    de Bortoli Cassiani, Silvia Helena
    [J]. EINSTEIN-SAO PAULO, 2021, 19 : eAO6011
  • [27] Effect of mental health nurses' beliefs and knowledge of medication on their use of strategies to improve medication adherence
    Drori, Tal
    Guetta, Hava
    Ben Natan, Merav
    Polakevich, Yaakov
    [J]. INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2014, 23 (04) : 374 - 380
  • [28] Optimizing Medication Adherence: An Ongoing Opportunity To Improve Outcomes After Kidney Transplantation
    Prendergast, Mary B.
    Gaston, Robert S.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (07): : 1305 - 1311
  • [29] Expanding patient access to quality medication-related information: the potential of medication hotlines to improve patient adherence in schizophrenia
    Pettit, Amy R.
    Marcus, Steven C.
    [J]. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2015, 50 (05) : 735 - 737
  • [30] Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care
    Ascher-Svanum, H
    Faries, DE
    Zhu, BJ
    Ernst, FR
    Swartz, MS
    Swanson, JW
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (03) : 453 - 460